{
    "name": "iron/folic acid/vitamin/mineral",
    "comment": "Rx",
    "other_names": [
        "Irospan 24/6",
        "Nephron FA",
        "Corvite FE"
    ],
    "classes": [
        "Vitamins",
        "Combos"
    ],
    "source": "https://reference.medscape.com/drug/irospan-24-6-nephron-fa-iron-folic-acid-vitamin-mineral-999967",
    "pregnancy": null,
    "lactation": null,
    "warnings": {
        "black_box_warning": {
            "common": [
                "Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years",
                "Keep product out of reach of children",
                "In case of accidental overdose, call a doctor or poison control center immediately",
                "Initial symptoms of acute overdose may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock, and coma"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Ingesting >3 g of omega-fatty acids/day has potential antithrombotic effects, including increased bleeding time and INR; avoid omega-3 fatty acids in patients on anticoagulants and in those known to have a bleeding diathesis",
                "Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient",
                "Hemochromatosis and hemosiderosis are contraindications to iron therapy"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Do not exceed recommended dose",
                "Determine the type of anemia and the underlying cause or causes before starting therapy",
                "Folic acid >1 mg/day may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive",
                "Exclude the diagnosis of pernicious anemia before beginning therapy with folic acid (may mask symptom of pernicious anemia)",
                "Irospan contains formate, which if consumed above the recommended level, could cause visual impairment and other health effects; do not take more than the recommended amount"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "pafolacianine",
            "description": {
                "common": "iron/folic acid/vitamin/mineral decreases effects of pafolacianine by receptor binding competition. Avoid or Use Alternate Drug. Avoid coadministration with folic acid or folic acid-containing supplements for 48 hr before administering pafolacianine. Use of folate, folic acid, or folate-containing supplements may reduce binding of pafolacianine to folate receptors overexpressed on ovarian cancer cells and could reduce the detection of malignant lesions with. ."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "omadacycline",
            "description": {
                "common": "iron/folic acid/vitamin/mineral will decrease the level or effect of omadacycline by  inhibition of GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Separate dosing of tetracyclines from these products. "
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sarecycline",
            "description": {
                "common": "iron/folic acid/vitamin/mineral will decrease the level or effect of sarecycline by  inhibition of GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Separate dosing of tetracyclines from these products. "
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Iron",
            "percent": null
        },
        {
            "name": "Constipation",
            "percent": null
        },
        {
            "name": "diarrhea",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "dark stools",
            "percent": null
        },
        {
            "name": "and abdominal pain",
            "percent": null
        },
        {
            "name": "Folic acid",
            "percent": null
        },
        {
            "name": "Allergic sensitization",
            "percent": null
        }
    ]
}